Tuesday, May 18, 2021

Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial

A COVID-19 vaccine developed by pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) has shown strong rates of neutralising antibody responses against the infectious Coronavirus disease in the Phase-II trial.

from Zee News :Zee News - Health https://ift.tt/3hyEotX
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Monsoon skincare mistakes that could be ruining your skin and how to fix them

The humid monsoon season can trigger excess oil, clogged pores, breakouts and dull skin if you stick to your summer skincare routine. Exper...